IP Library Patent Application 18653891
Patent Application
App. No. 18/653,891

ANTI-AGING COMPOSITIONS FOR SENSITIVE SKIN

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/653,891
Abstract

Aspects of the present disclosure include compositions and methods for treating, preventing, or improving dermatocosmetic conditions, the composition comprising topical formulations containing a combination of niacinamide and galactoarabinan.

Claims (31)

1 . A storage stable, topical composition comprising:

a. 1% to 20% by weight niacinamide; and

b. 0.2% to 10% by weight galactoarabinan,

wherein the composition is dissolved in an aqueous solvent and comprises a pH ranging from 2.5 to 7.0.

2 . The storage stable, topical composition consists essentially of:

a. 1% to 20% by weight niacinamide; and

b. 0.2% to 10% by weight galactoarabinan,

wherein the composition is dissolved in an aqueous solvent and comprises a pH ranging from 2.5 to 7.0.

3 . The storage stable, topical composition of claim 1 , wherein the composition does not comprise N-Acetylglucosamine (GlcNAc).

4 . The storage stable, topical composition of any one of claims 1-3 , wherein the pH ranges from 4 to 7.

5 . The storage stable, topical composition of any one of claims 1-4 , wherein the composition comprises 5% Niacinamide.

6 . The storage stable, topical composition of any one of claims 1-5 , wherein the composition comprises 2% Galactoarabinan.

7 . The storage stable, topical composition of any one of claims 1-6 , wherein the composition comprises 30%-40% of the aqueous solvent.

8 . The storage stable, topical composition of any one of claims 1-7 , wherein the composition comprises 35%-40% of the aqueous solvent.

9 . The storage stable, topical composition of any one of claims 1-8 , wherein the aqueous solvent is water.

10 . The storage stable, topical composition of any one of claims 1-9 , wherein the composition further comprises one or more non-aqueous solvents.

11 . The storage stable, topical composition of claim 10 , wherein the one or more non-aqueous solvents is selected from the group consisting of: 1,3 propanediol, 1,2 propanediol, 1,3 butanediol, 1,5 pentanediol, 1,2 hexanediol, 1,6 hexanediol, glycerol, diglycerol, ethoxydiglycol, and dimethyl isosorbide.

12 . The storage stable, topical composition of any one of claims 1-11 , wherein the one or more non-aqueous solvents is propanediol.

13 . The storage stable, topical composition of any one of claims 1-11 , wherein the one or more non-aqueous solvent is a mixture of propanediol and glycerin.

14 . The storage stable, topical composition of any one of claims 1-13 , wherein the composition further comprises 5% to 15% by weight of one or more acidifying agents.

15 . The storage stable, topical composition of claim 14 , wherein the one or more acidifying agents is selected from the group consisting of: gluconolactone, salicylic acid, and a phytic acid solution.

16 . The storage stable, topical composition of any one of claims 14-15 , wherein the one or more acidifying agents comprises 5-20% by weight of gluconolactone.

17 . The storage stable, topical composition of any one of claims 14-16 , wherein the one or more acidifying agents comprises 0.001 to 3% of salicylic acid.

18 . The storage stable, topical composition of any one of claims 14-17 , wherein the one or more acidifying agents comprises 0.001 to 3% of and a phytic acid solution.

19 . The storage stable, topical composition of any one of claims 1-16 , wherein the composition further comprises one or more additional components.

20 . The storage stable, topical composition of claim 17 , wherein the one or more additional components is selected from the group consisting of: Tranexamic Acid, Madecassoside, Pinus Pinaster Bark Extract in Diglycerin, Caprylhydroxamic acid, 1,2-Hexanediol and Propanediol.

21 . The storage stable, topical composition of claim 18 , wherein the composition comprises 3% Tranexamic Acid, 0.2% Madecassoside, 0.5% Pinus Pinaster Bark Extract in Diglycerin, and a mixture of 1% Caprylhydroxamic acid, 1,2-Hexanediol and Propanediol.

22 . The storage stable, topical composition of any one of claims 1-21 , wherein the composition is in the form of a serum, lotion, or cream.

23 . A ready-to-use topical preparation in a multi-use container which is pre-filled with a storage stable topical composition according to any one of claims 1-22 , wherein the multi-use container comprises means for dispensing a single dose of the storage stable topical composition.

24 . The preparation of claim 23 , wherein the storage stable topical composition is sealed from the atmosphere in the container.

25 . The preparation of any one of claims 22-24 , wherein the container is placed in packaging.

Assignments (3)
ASSET PURCHASE AGREEMENT Recorded Apr 11, 2025
From: ICB (AN ABC), LLC
To: MF BEAUTY PARTNERS LLC
Reel/Frame 070820/0964 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2025
From: BAEK CLINICAL INC.
To: ICB (AN ABC), LLC
Reel/Frame 070781/0445 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2025
From: BAEK, JIHOON P.
To: BAEK CLINICAL INC.
Reel/Frame 070754/0664 →